Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Información selecta para pacientes y cuidadores que se encuentra disponible en Español.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our medical information is accurate, up to date, and scientifically balanced.

ZARONTIN® Oral Solution (ethosuximide)

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our medical information is accurate, up to date, and scientifically balanced.

ZARONTIN® Oral Solution Quick Finder

INDICATIONS AND USAGE

Zarontin is indicated for the control of absence (petit mal) epilepsy.

Did you find an answer to your question? Yes No

DOSAGE AND ADMINISTRATION

Zarontin is administered by the oral route. The initial dose for patients 3 to 6 years of age is one teaspoonful (250 mg) per day; for patients 6 years of age and older...

Did you find an answer to your question? Yes No

CONTRAINDICATIONS

Ethosuximide should not be used in patients with a history of hypersensitivity to succinimides.

Did you find an answer to your question? Yes No

WARNINGS

Blood dyscrasias

Blood dyscrasias, including some with fatal outcome, have been reported to be associated with the use of ethosuximide; therefore, periodic...

Did you find an answer to your question? Yes No

ADVERSE REACTIONS

Body As A Whole: Allergic reaction, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).

Gastrointestinal System: Gastrointestinal symptoms...

Did you find an answer to your question? Yes No

OVERDOSAGE

Acute overdoses may produce nausea, vomiting, and CNS depression including coma with respiratory depression. A relationship between ethosuximide toxicity and its plasma levels has not been established. The...

Did you find an answer to your question? Yes No

DESCRIPTION

Zarontin (ethosuximide) is an anticonvulsant succinimide, chemically designated as alpha-ethyl-alpha-methyl-succinimide, with the following structural formula:

...
Did you find an answer to your question? Yes No

CLINICAL PHARMACOLOGY

Ethosuximide suppresses the paroxysmal three cycle per second spike and wave activity associated with lapses of consciousness which is common in absence (petit mal) seizures. The frequency of...

Did you find an answer to your question? Yes No

HOW SUPPLIED

Zarontin is supplied as:

NDC 0071-2418-23: 1 pint amber glass bottles.

NDC 0071-2418-35: 1 pint amber polyethylene terephthalate (PET) bottles.

Each 5 mL of oral...

Did you find an answer to your question? Yes No

MEDICATION GUIDE

ZARONTIN, (Ză rŏn' tĭn)
(ethosuximide)

Capsules, Oral Solution

Read this Medication Guide before you start taking ZARONTIN and each time...

Did you find an answer to your question? Yes No

Company Logo

LAB-0093-11.0

Revised May 2019

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event